About
We are a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions.
At Karuna, we understand there is a need for differentiated treatments that can help patients as they navigate the challenges presented by these complex conditions. Utilizing our extensive knowledge of neuroscience, we are pursuing novel pathways to develop medicines with the potential to make a meaningful difference in peoples’ lives.
Our Team
Karuna Therapeutics is bringing together a community of scientists, clinicians, and leaders with deep expertise in neuroscience and drug development.
Steve Paul, M.D.
Chairman of the Board, President and Chief Executive Officer
Stephen Brannan, M.D.
Chief Medical Officer
Andrew Miller, Ph.D.
Founder and Chief Operating Officer
Troy A. Ignelzi
Chief Financial Officer
Giorgio Attardo, Ph.D.
Vice President, CMC and Preclinical Development
Jim Audia, Ph.D.
Head of Medicinal Chemistry and Senior Adviser
Gregory T. Brophy, Ph.D.
Head of Regulatory and Senior Adviser
Jason Brown
Vice President, Corporate Finance
Christian Felder, Ph.D.
Vice President, Discovery Research
Inder Kaul, M.D., MPH
Vice President, Clinical Development
Mia Kelley, J.D.
Vice President, Legal Affairs
Ron Marcus, M.D.
Senior Vice President, Medical
Jim Monn, Ph.D.
Vice President, Medicinal Chemistry
Stephanie Moore
Vice President, Human Resources
Sharon Sawchak, R.N.
Vice President, Clinical Operations and Compliance
Gregg A. Pratt, Ph.D
Vice President, Regulatory Affairs
Andrew Parratt
Vice President, Commercial Planning & Operations
Peter Weiden, M.D.
Vice President, Medical
Board of Directors
Steve Paul, M.D.
Chairman of the Board, President and Chief Executive Officer
Christopher J. Coughlin
Former Advisor to the Chairman and CEO & Executive Vice president and Chief Financial Officer, Tyco International Ltd.
Jim Healy, M.D., Ph.D.
General Partner, Sofinnova Investments
Jeff Jonas, M.D.
Chief Innovation Officer, Sage Therapeutics
Robert Nelsen, MBA
Co-Founder and Managing Director, Arch Venture Partners
Laurie Olson
Former Executive Vice President of Strategy and Commercial Operations at Pfizer Inc.
Atul Pande, M.D.
Former Senior Vice President, Head of Neuroscience and Senior Advisor, Pharmaceutical R&D at GlaxoSmithKline; Member, Karuna Therapeutics Scientific Advisory Board
Heather Preston, M.D.
Managing Partner, Pivotal bioVenture Partners
Denice Torres
CEO of The Ignited Company, Founder of The Mentoring Place, former Chief Strategy and Business Transformation Officer, Medical Device, Johnson & Johnson
David Wheadon, M.D.
Former SVP, Global Regulatory Affairs, Patient Safety and Quality Assurance, AstraZeneca Pharmaceuticals
Scientific Advisory Board
Alan Breier, M.D.
Chief Clinical Advisor & Chair, Karuna Scientific Advisory Board; Senior Professor of Psychiatry, Indiana University Mental Health Research and Education; Vice-Chair for Clinical Research; Chief, IU Psychotic Disorders Program; Director, Prevention and Recovery Center (PARC), Indiana University School of Medicine
Edmund Harrigan, M.D.
Former SVP, Worldwide Safety & Regulatory, Pfizer, Inc.
Richard Keefe, Ph.D.
Professor of Psychiatry, Psychology, and Neurosciences, Duke University Medical Center
Allan Levey, M.D., Ph.D.
Professor & Chair, Department of Neurology at Emory University; Director, Goizueta Alzheimer’s Disease Research Center
Jeffrey Lieberman, M.D.
Lawrence C. Kolb Professor and Chairman, Department of Psychiatry, Columbia University College of Physicians and Surgeons; Director, New York State Psychiatric Institute; Psychiatrist-in-Chief of the New York-Presbyterian Hospital – Columbia University Medical Center.
Atul Pande, M.D.
Former Senior Vice President, Head of Neuroscience and Senior Advisor, Pharmaceutical R&D at GlaxoSmithKline; Board Member, Karuna Therapeutics
William Z. Potter, M.D., Ph.D.
Former VP, Translational Neuroscience, Merck; Former Head of Early Clinical Development, Eli Lilly
Anantha Shekhar, M.D., Ph.D.
Senior Vice Chancellor for the Health Sciences, University of Pittsburgh; John and Gertrude Petersen Dean, Professor of Psychiatry, School of Medicine, University of Pittsburgh; Professor of Clinical and Translational Science, Clinical and Translational Science Institute, University of Pittsburgh
Carol A. Tamminga, M.D.
Lou and Ellen McGinley Distinguished Chair and the McKenzie Chair in Psychiatry at the University of Texas Southwestern Medical School; Chairman of the Department of Psychiatry; Chief of the Translational Neuroscience Division in Schizophrenia at UT Southwestern